A randomized double-blind phase II study to evaluate same-day vs nex-day pegfilgrastim with carboplatin and docetaxel in patients with NSCLC

Chandra Belani, S. Ramalingam, A. Al-Janadi, E. Eskander, H. Ghazal, L. Schwartzberg, M. Elliott, S. Shahin, L. Dreiling

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)30-31
Number of pages2
JournalJournal of Supportive Oncology
Volume5
Issue number4 SUPPL. 2
StatePublished - Apr 1 2007

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

Belani, C., Ramalingam, S., Al-Janadi, A., Eskander, E., Ghazal, H., Schwartzberg, L., Elliott, M., Shahin, S., & Dreiling, L. (2007). A randomized double-blind phase II study to evaluate same-day vs nex-day pegfilgrastim with carboplatin and docetaxel in patients with NSCLC. Journal of Supportive Oncology, 5(4 SUPPL. 2), 30-31.